Alterity Therapeutics Limited (ATHE)

NASDAQ: ATHE · Real-Time Price · USD

4.565

0.00 (0.00%)

Jul 29, 2026, 11:35 AM EDT - Market open

Alterity Therapeutics Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Cash & Equivalents	49.2	33.16	12.64	15.77	34.81	28.12
Cash & Short-Term Investments	49.2	33.16	12.64	15.77	34.81	28.12
Cash Growth	48.38%	162.35%	-19.87%	-54.68%	23.80%	205.71%
Accounts Receivable	6.84	3.94	4.04	8.67	4.73	4.28
Other Current Assets	0.78	8.77	2.36	2.61	1.61	1.1
Total Current Assets	56.82	45.87	19.04	27.05	41.14	33.49
Net Property, Plant & Equipment	0.1	0.16	0.19	0.27	0.22	0.1
Total Assets	56.92	46.03	19.22	27.32	41.36	33.59

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Accounts Payable	1.6	2.58	4.62	3.52	5.08	2.5
Accrued Expenses	0.94	0.88	0.53	0.73	0.66	0.54
Current Portion of Leases	0.03	0.07	0.11	0.11	0.06	0.03
Other Current Liabilities	0.02	0.02	0.12	0.03	0.03	-
Total Current Liabilities	2.59	3.53	5.37	4.38	5.82	3.07
Long-Term Leases	0.07	0.09	0.05	0.1	0.06	0.04
Other Long-Term Liabilities	-	-	-	0.02	0.01	0.01
Total Long-Term Liabilities	0.07	0.09	0.05	0.12	0.07	0.05
Total Liabilities	2.65	3.62	5.43	4.5	5.89	3.12

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Common Stock	282.51	262.95	223.15	213.97	213.79	197.45
Additional Paid-in Capital	6.13	5.34	4.81	3.97	3.57	2.75
Retained Earnings	-234.38	-225.89	-214.16	-195.13	-181.88	-169.73
Shareholders' Equity	54.27	42.4	13.8	22.81	35.47	30.47
Total Liabilities & Equity	56.92	46.03	19.22	27.32	41.36	33.59

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Total Debt	0.1	0.16	0.16	0.21	0.12	0.07
Net Cash (Debt)	49.1	33	12.48	15.56	34.69	28.05
Net Cash Growth	48.78%	164.45%	-19.81%	-55.13%	23.67%	206.12%
Net Cash Per Share	166.82	154.78	102.61	192.31	432.54	-
Book Value	54.27	42.4	13.8	22.81	35.47	30.47
Book Value Per Share	184.38	198.86	113.44	281.89	442.25	-
Tangible Book Value	54.27	42.4	13.8	22.81	35.47	30.47
Tangible Book Value Per Share	184.38	198.86	113.44	281.89	442.25	-

SEC Filings: 10-K · 10-Q